-

Pharma Innovator Modernizes Cleaning Validation with ValGenesis iClean™

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, today announced that an international pharmaceutical company has selected ValGenesis iClean™ to modernize its cleaning validation operations and enhance compliance.

ValGenesis iClean™ streamlines cleaning process design and execution through risk-based strategies and compliant evidence capture, reducing the operational burden associated with large, paper-based validation programs.

Share

ValGenesis iClean™ is a purpose-built application within the ValGenesis Validation Lifecycle Suite (VLS), used by global pharmaceutical organizations to digitalize cleaning validation operations across manufacturing facilities. iClean streamlines cleaning process design and execution through risk-based strategies and compliant evidence capture, reducing the operational burden associated with large, paper-based validation programs.

The application will support the oversight of more than a dozen active pharmaceutical ingredients, scaling alongside the company’s growing product portfolio while enabling more robust toxicity- and solubility-based risk assessments and preserving critical process knowledge in a centralized system. The implementation marks the beginning of a broader digital transformation initiative, starting at a single manufacturing site and expanding to additional sites over time.

“This partnership reflects how pharmaceutical organizations are embracing digital solutions to bring greater rigor and scalability to cleaning validation,” said Steve Reynolds, chief revenue officer at ValGenesis. “With iClean, customers can replace manual spreadsheets with a compliant, data-driven approach that not only centralizes cleaning data but also streamlines execution and improves the efficiency of day-to-day validation operations.”

About ValGenesis, Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com.

Contacts

For further information, contact:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

ValGenesis Inc.


Release Versions

Contacts

For further information, contact:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis Inc.

ValGenesis Appoints David Horn as President 

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, the global leader in digital validation and lifecycle management solutions for the life sciences industry, today announced the appointment of David Horn as president, effective Oct. 5, 2026.Horn joins ValGenesis as the company expands its Smart GxP™ platform and VAL™ (ValGenesis AI) capabilities. As president, he will focus on strengthening the company’s financial and operating foundation, supporting global growth, and expanding relationships wit...

ValGenesis to Bring Real-World AI-Assisted Validation Insights to KENX Europe 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis will share real-world AI-assisted validation insights from customer pilots and production deployments at KENX Europe 2026....

Eugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSV

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in enterprise digital validation, announced that Eugia Pharmaceuticals, a global specialty pharmaceutical company, has gone live with ValGenesis to modernize computer system validation (CSV) processes across its sites in India. The deployment will help enhance compliance, improve operational efficiency, and support growth. Hyderabad-based Eugia Pharma, a subsidiary of Aurobindo Pharma, develops and markets complex generics. The...
Back to Newsroom